Publications by authors named "Rachel Belk"

Claim this Profile
T
The theoretical and practical determination of clinical cut-offs for the British Sign Language versions of PHQ-9 and GAD-7.
Rachel A Belk, Mark Pilling, Katherine D Rogers, Karina Lovell, Alys Young

BMC Psychiatry· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translation, validity and reliability of the British Sign Language (BSL) version of the EQ-5D-5L.
Katherine D Rogers, Mark Pilling, Linda Davies, Rachel Belk, Catherine Nassimi-Green

Qual Life Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A qualitative exploration of trial-related terminology in a study involving Deaf British Sign Language users.
Alys Young, Rosemary Oram, Claire Dodds, Catherine Nassimi-Green, Rachel Belk

Trials· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interventions to improve patient access to and utilisation of genetic and genomic counselling services.
Caroline M Benjamin, Lois H Thomas, Heather Skirton, Shanna Gustafson, Jacqueline Coupe, Rachel Belk

Cochrane Database Syst Rev· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.
Louise M Byrd, Andrew Shenton, Eamonn R Maher, Emma Woodward, Rachel Belk

Cancer Epidemiol Biomarkers Prev· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproductive liberty and deafness: Clause 14(4)(9) of embryo bill should be amended or deleted.
Steve Emery, Teresa Blankmeyer Burke, Anna Middleton, Rachel Belk, Graham Turner

BMJ· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation analyses of Uroplakin II in children with renal tract malformations.
Dagan Jenkins, Maria Bitner-Glindzicz, Sue Malcolm, Jennifer Allison, Rose de Bruyn, Rachel A Belk

Nephrol Dial Transplant· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo Uroplakin IIIa heterozygous mutations cause human renal adysplasia leading to severe kidney failure.
Dagan Jenkins, Maria Bitner-Glindzicz, Sue Malcolm, Chih-Chi A Hu, Jennifer Allison, Rachel A Belk

J Am Soc Nephrol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1/2 predictive testing: a study of uptake in two centres.
Lucy Brooks, Fiona Lennard, Andrew Shenton, Fiona Lalloo, Ingrid Ambus, Rachel Belk

Eur J Hum Genet· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis